PRECISEU
The European PRECISEU project has become a model for international collaboration and knowledge transfer, driving research translation to clinical practice and access to cutting-edge treatments.
2024 was a pivotal year for consolidating PRECISEU (PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope), which is a major European project in personalized medicine and advanced therapies, coordinated by Biocat under the Horizon Europe Program. This initiative, with nearly €23 million in funding, brings together 25 partners from 12 European regions in 10 Member States and Ukraine, with Catalonia standing out as the region with the most participants and institutional leadership. Catalan partners include, in addition to Biocat, the Catalan Ministry of Health, ACCIÓ, Barcelona Supercomputing Center and AstraZeneca.
The project officially kicked off in Barcelona, with a public presentation at the Palau de la Generalitat that brought together more than a hundred professionals and institutional representatives.
In 2024, PRECISEU laid the groundwork to accelerate the adoption of personalized medicine in Europe through actions that included:
Defining an interregional ecosystem to facilitate the translation of research to clinical practice and access to advanced treatments.
Creating a technology platform for health data integration, which is key to developing new personalized solutions.
Promoting public-private partnership, leveraging Catalonia’s experience with projects like PASS and the Advanced Therapies Hub of Catalonia, and the active participation of companies and research institutions.
Holding panel discussions and work sessions to identify challenges and opportunities, such as biomarker development, clinical validation of new therapies and healthcare system sustainability.
PRECISEU was also one of five winning projects in the European Commission’s Regional Innovation Valleys (RIV) call, and the first to sign the agreement with the Commission to launch the project.
